Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological relevance of CDK inhibitors in Alzheimer's disease
Nishtha Malhotra, Rohan Gupta, Pravir Kumar
Neurochemistry International (2021) Vol. 148, pp. 105115-105115
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Challenges and hopes for Alzheimer’s disease
Suren A. Tatulian
Drug Discovery Today (2022) Vol. 27, Iss. 4, pp. 1027-1043
Closed Access | Times Cited: 190
Mouse Models of Alzheimer’s Disease
Miyabishara Yokoyama, Honoka Kobayashi, Lisa Tatsumi, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 125
Neuronal cell death mechanisms in Alzheimer’s disease: An insight
Parul Goel, Sasanka Chakrabarti, Kapil Goel, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 120
Targeting CDK1 in cancer: mechanisms and implications
Qiushi Wang, Ann M. Bode, Tianshun Zhang
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 74
Lessons Learned from Past Cyclin-Dependent Kinase Drug Discovery Efforts
Zhouling Xie, Shuzeng Hou, Xiaoxiao Yang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 9, pp. 6356-6389
Closed Access | Times Cited: 46
From Structure Modification to Drug Launch: A Systematic Review of the Ongoing Development of Cyclin-Dependent Kinase Inhibitors for Multiple Cancer Therapy
Zhenfeng Shi, Lei Tian, Taotao Qiang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 9, pp. 6390-6418
Closed Access | Times Cited: 40
Inhibition of CDK4/6 regulates AD pathology, neuroinflammation and cognitive function through DYRK1A/STAT3 signaling
Hyunju Lee, Hyang‐Sook Hoe
Pharmacological Research (2023) Vol. 190, pp. 106725-106725
Open Access | Times Cited: 22
Slower CDK4 and faster CDK2 activation in the cell cycle
Wengang Zhang, Yonglan Liu, Hyunbum Jang, et al.
Structure (2024) Vol. 32, Iss. 8, pp. 1269-1280.e2
Closed Access | Times Cited: 8
Small molecule ‘4ab’ induced autophagy and endoplasmic reticulum stress-mediated death of aggressive cancer cells grown under adherent and floating conditions
Sameer Ullah Khan, Kaneez Fatima, Umed Singh, et al.
Medical Oncology (2023) Vol. 40, Iss. 4
Closed Access | Times Cited: 16
New 1,3,4-thiadiazoles as potential anticancer agents: pro-apoptotic, cell cycle arrest, molecular modelling, and ADMET profile
Mohamed H. Hekal, Paula S. Farag, Magdy M. Hemdan, et al.
RSC Advances (2023) Vol. 13, Iss. 23, pp. 15810-15825
Open Access | Times Cited: 16
Network toxicological and molecular docking to investigate the mechanisms of toxicity of agricultural chemical Thiabendazole
Junhui He, Xiufang Zhu, Kaimeng Xu, et al.
Chemosphere (2024) Vol. 363, pp. 142711-142711
Closed Access | Times Cited: 6
Cyclin‐dependent kinases: Masters of the eukaryotic universe
Aleksandra J. Pluta, Cécilia Studniarek, Shona Murphy, et al.
Wiley Interdisciplinary Reviews - RNA (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 13
p27, The Cell Cycle and Alzheimer´s Disease
Ana García‐Osta, Jinya Dong, María J. Moreno‐Aliaga, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1211-1211
Open Access | Times Cited: 20
Two new alkaloids from Dendrobium nobile Lindl. exhibited neuroprotective activity, and dendrobine alleviated Aβ1−42‐induced apoptosis by inhibiting CDK5 activation in PC12 cells
Cheng‐Chen Zhang, Yan‐Li Kong, Mao‐Sheng Zhang, et al.
Drug Development Research (2023) Vol. 84, Iss. 2, pp. 262-274
Open Access | Times Cited: 10
Navigating the GSK-3β inhibitors as versatile multi-target drug ligands in Alzheimer’s disease intervention – A comprehensive review
Nachiket Jitendra Joshi, Rajasekhar Reddy Alavala
Results in Chemistry (2024) Vol. 7, pp. 101500-101500
Open Access | Times Cited: 3
Triaging between post-translational modification of cell cycle regulators and their therapeutics in neurodegenerative diseases
Neetu Rani, Mehar Sahu, Rashmi K. Ambasta, et al.
Ageing Research Reviews (2023) Vol. 94, pp. 102174-102174
Closed Access | Times Cited: 8
Discovery of Potential Inhibitors of CDK1 by Integrating Pharmacophore-Based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation Studies, and Evaluation of Their Inhibitory Activity
Vineeta Teotia, Prakash Jha, Madhu Chopra
ACS Omega (2024)
Open Access | Times Cited: 2
Accurate prediction and key protein sequence feature identification of cyclins
Shaoyou Yu, Bo Liao, Wen Zhu, et al.
Briefings in Functional Genomics (2023) Vol. 22, Iss. 5, pp. 411-419
Closed Access | Times Cited: 7
Shared peripheral blood biomarkers for Alzheimer’s disease, major depressive disorder, and type 2 diabetes and cognitive risk factor analysis
Yu Zhang, Rulin Geng, Miao Liu, et al.
Heliyon (2023) Vol. 9, Iss. 3, pp. e14653-e14653
Open Access | Times Cited: 6
Synthesis of 6,8-diaminopurines via acid-induced cascade cyclization of 5-aminoimidazole precursors and preliminary anticancer evaluation
Nádia Senhorães, Bruna F. Silva, Raquel Sousa, et al.
Organic & Biomolecular Chemistry (2024) Vol. 22, Iss. 7, pp. 1500-1513
Closed Access | Times Cited: 1
MicroRNA-based interventions in aberrant cell cycle diseases: Therapeutic strategies for cancers, central nervous system disorders and comorbidities
Xiaojuan Tang, Yuan Ren, Wen Zeng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116979-116979
Open Access | Times Cited: 1
Binding Modalities and Phase-Specific Regulation of Cyclin/Cyclin-Dependent Kinase Complexes in the Cell Cycle
Michael T. Bergman, Wengang Zhang, Yonglan Liu, et al.
The Journal of Physical Chemistry B (2024)
Closed Access | Times Cited: 1
Monoterpenoid indole alkaloid dimers from Kopsia arborea inhibit cyclin-dependent kinase 5 and tau phosphorylation
Chen Chen, Jianwen Liu, Ling‐Li Guo, et al.
Phytochemistry (2022) Vol. 203, pp. 113392-113392
Closed Access | Times Cited: 8
Cell cycle progression mechanisms: slower cyclin-D/CDK4 activation and faster cyclin-E/CDK2
Wengang Zhang, Yonglan Liu, Hyunbum Jang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Ameliorating Alzheimer’s-like Pathology by Minocycline via Inhibiting Cdk5/p25 Signaling
Yu Zhao, Chuanling Wang, Wenbo He, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 9, pp. 1783-1792
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top